Headache in stroke: use of the international Headache Society classification.

References 1. Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology. In press. 2. Dungan DD, Jay MS. Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies. Pediatrics. 1992;90:96-99. 3. Tsokos GC, Tsokos M, le Riche NGH, Klippel JH. A clinical and pathological study of cerebrovascular disease in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1986;16: 70-78. 4. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology. 1993;43:2069-2073. 5. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992;23:189-193. 6. Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellmann D, Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med. 1987;106:524-531. 7. Boey ML, Colaco CB, Elkon KB, Loizou S, Hughes GRV. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. BMJ. 1983; 287:1021-1023. 8. Brey RL, Coull BM. Antiphospholipid antibodies: origin, specificity, and mechanism of action. Stroke. 1992;23(suppl I):I-15-I-18. 9. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet. 1993;342:341-344. 10. Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid antibodies by immunization with a lipid binding protein, B2-glycoprotein I. Lupus. 1992;l(suppl):150. Abstract. 11. Bevers EM, Galli M. Co-factors involved in the antiphospholipid syndrome. Lupus. 1992;l:51-54. 12. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992; 117:303-308. 13. Levine SR, Brey RL, Joseph CLM, Havstad S, on behalf of the Antiphospholipid Antibodies in Stroke Study Group. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke. 1992;23(suppl